17.244.17% ( -0.75 )
Delay Closed: Nov 16, 15:00:00Valuation
Current ValuationThe current P/E ratio is 49.39, below the reasonable range, cheaper than 95.65% of the time in the past 1 years, and the industry ranks 105/222, the industry Median 22.19.
49.39xP/E
¥17.24Stock price
¥0.35Earnings per share
49.39xP/E
Stock price¥17.24Earnings per share¥0.35
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 58.71x
- Typical range
- 53.95x–67.30x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 22.19x
015304560
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 22.19x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
600436SHZZPZH | 59.62x | 17.36% | ¥78.51B |
002653SZHaisco | 48.63x | 572.55% | ¥63.39B |
002821SZAsymchem | 43.83x | 16.47% | ¥51.91B |
300765SZCSPC Innovation | 46.24x | 628.47% | ¥45.90B |
002294SZSalubris | 46.03x | 29.31% | ¥32.91B |
300199SZHYBIO | 48.42x | -- | ¥19.46B |
603858SHBUCHANG PHARMA | 56.02x | -- | ¥15.79B |
301569SZNOVAST | 49.39x | -- | ¥15.37B |
002626SZKingdomway | 43.61x | 26.67% | ¥10.16B |
300725SZPHARMABLOCK | 45.32x | 18.18% | ¥10.04B |
600851SHHX GROUP | 51.45x | -- | ¥9.83B |
600789SHLKPC | 52.53x | -- | ¥7.16B |
688553SHHUIYU PHARMACEUTICAL | 49.72x | -- | ¥6.42B |
688799SHHWPC | 51.27x | 24.46% | ¥5.84B |
002390SZxinbang phar. | 41.58x | -- | ¥5.75B |
301393SZHighfine | 46.41x | -- | ¥5.72B |
002907SZPharscin Pharma | 56.52x | -- | ¥5.30B |
002940SZALK | 41.02x | -- | ¥4.53B |
301281SZKeyuan Pharma | 54.97x | -- | ¥3.87B |
300584SZHicin Pharmaceutical | 48.90x | -- | ¥3.50B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
